Icl Group Ltd. · TASE:ICL
Icl — Investor Day (September 2020)
14 slides from Icl's investor day presentation, Sep 23, 2020
Slide 1: Leadership, Innovation, Growth
Leadership Innovation Growth RADO SPORKA V P F O O D S P E C I A LT I E S 1
Slide 2: Important Legal Notes
Important Legal Notes !"#$%&"'()*&+,*-&.(*/&)01)*.1)*21)3&),45116"+7*-8&8('(+8#! ! "#$! %&'()*+,(&! -(&.+%&$/! #$)$%&! %&! .#%0! 1)$0$&.+,(&! ()! /$2%3$)$/! ()! .(! 4$! /$2%3$)$/! .(! 5(6! /6)%&7! (6)! 1)$0$&.+,(&! /($0! &(.! -(&0,.6.$! +&! (8$)9! $:1)$00$/! ()! %*12%$/9! ()! +! )$-(**$&/+,(&!.(!/(!
Slide 3: Phosphate Specialties Robust Performance
*PHOSPHATE SPECIALTIES ROBUST PERFORMANCE 18% 14% 13% 10% ~300 110 162 149 2017 2018 2019 2025 EBITDA EBITDA margin 3 million $ * Targeted
Slide 4: ICL Food Specialties: The Specialist in Functional Ingredients
ICL FOOD SPECIALTIES THE SPECIALIST IN FUNCTIONAL INGREDIENTS MEAT, POULTRY, DAIRY & VEGAN, VEGETARIAN INFANT SEAFOOD BEVERAGE BAKERY & FLEXITARIAN NUTRITION We enhance We help dairy We help bakery We deliver We ensure the TASTE & products have the products RISE desired TEXTURE premium ORGANIC MOUTH
Slide 5: Strong Global Presence with Balance Across Major Food Categories
STRONG GLOBAL PRESENCE WITH BALANCE ACROSS MAJOR FOOD CATEGORIES Total sales of $560m in 2019 Dairy & NA Europe Beverage Bakery $170M $160M $130m $130m Africa/ME Asia/Pacifc $30M $140M SA $60M Meat Infant $150m Nutrition $150m “Glocal” full integration production plan > 5 Innovation & Application Ce
Slide 6: Customer Centric Innovation as a Key Driver of Our Business Model
CUSTOMER CENTRIC INNOVATION AS A KEY DRIVER OF OUR BUSINESS MODEL IngredIent SolutIonS MEAT, POULTRY, SEAFOOD Healthier & Organic DAIRY & Afordable PHOSPHATES TEXTURIZERS BEVERAGE Shelf-stable BAKERY Protein Enriched Appealing & Well SPICES & VEGAN, Tasting PROTEINS FLAVOR VEGETARIAN & FLEXITARIAN 6
Slide 7: Innovation Is Expected to Drive Our Growth for the Next 5 Years
INNOVATION IS EXPECTED TO DRIVE OUR GROWTH FOR THE NEXT 5 YEARS *REVENUE CONTRIBUTIO N OVER NEXT 5 YEARS Growth of natural food across PROTEIN STABILIZATION world (organic, clean label) > ROVITARIS® for plant-based meat alternatives $100 > Plant-based dairy alternatives mio + > On-the-go high protei
Slide 8: ROVITARIS for Plant-Based Meat Alternatives
ROVITARIS® FOR PLANT-BASED MEAT ALTERNATIVES Global market for meat substitutes* to grow from $4.6B to $120B (26x) in next 7 years** Chicken nuggets > Unique texture Fish sticks FIBERS > White color Seafood > Neutral taste Burgers > Simple & clean label Meatballs TEXTURATES > Excellent binding prope
Slide 9: Building Front-End Innovation to Accelerate Long-Term Growth
BUILDING FRONT-END INNOVATION TO ACCELERATE LONG-TERM GROWTH Ingredients science Dedicated front-end Focused portfolio of 2500 BTB innovation organization leadership projects Customers > Systematic evaluation, > Natural clean label incl. Big Data mining ingredients Strategic > Upcoming protein sourc
Slide 10: ICL Food Specialties Growth Path
ICL FOOD SPECIALTIES GROWTH PATH 18% VALUE CREATING GROWTH > Protein stabilization > New protein source 11% > ROVITARIS® for plant-based meat alternatives > Solutions for emerging markets > Improved health & well-being $ 950M* > Supported by bolt on M&As and technology start-ups investments $ 560M >
Slide 11: Accelerated Growth Driven by Innovation
ACCELERATED GROWTH DRIVEN BY INNOVATION Building the infrastructure for * DOUBLE-DIGIT GROWTH in Specialty products beyond 2025 11 * Targeted
Slide 12: Thank you!
Thank you! ANICL
Slide 13: Reconciliation Tables
Reconciliation Tables !"#$%&'()*+,'-#$.&%+ /012+ /013+ /014+ /015+ !"#$%"&'()*%(+,&-.($) /012) /013) /014) !""#$%&'()*+,'-$ ./01$ !"#$%& '('20& '(')*& '(+),& '(*'-& !"#$%& '(')*& '('+,& '('''& !"#$%& '()& !"#$%&*+&$,*$-."#%& '/0& ./$0"123&42567$& ++8& +98& *::& **-& -.$/"012&31456$& *7& '',& '8)& 12
Slide 14: Non-GAAP Financial Measures
Non-GAAP Financial Measures We disclose in presentations non-IFRS fnancial measures titled adjusted EBITDA, segment EBITDA, segment EBITDA margin and free cash fow. Our management uses such non-GAAP measures to facilitate operating performance comparisons from period to period and present free cash